Stroke is a leading cause of morbidity and mortality globally, necessitating prompt recognition and management. This article elucidates the early signs of stroke and provides a comprehensive guide for its management.
Stroke symptoms often appear suddenly and primarily involve neurological deficits. The acronym FAST (Face drooping, Arm weakness, Speech difficulties, and Time to call emergency services) is a quick tool for identification. Other symptoms may include confusion, visual disturbances, dizziness, and severe headache. Early recognition is crucial as it directly affects the prognosis.
Upon suspecting a stroke, healthcare professionals should conduct a rapid assessment using validated tools such as the National Institutes of Health Stroke Scale (NIHSS). This is followed by immediate stabilization of vital signs, securing an airway if needed, and obtaining a non-contrast CT scan to differentiate between ischemic and hemorrhagic stroke.
Ischemic strokes can be managed with intravenous thrombolytics if presented within 4.5 hours of symptom onset. Endovascular thrombectomy is considered for large vessel occlusions. Hemorrhagic strokes require control of blood pressure, reversal of anticoagulation, and neurosurgical consultation. Both types necessitate secondary prevention strategies, including risk factor modification and antithrombotic therapy.
Post-stroke care involves a multidisciplinary team, including physiotherapists, speech and language therapists, and dieticians. This team approach aids in maximizing recovery and minimizing complications.
Early recognition and prompt management of stroke can significantly improve outcomes. Healthcare professionals play a vital role in this process, and their understanding of stroke signs and management strategies is paramount. Continuous education and training in stroke care are imperative to ensure the highest quality of care for these patients.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation